In another move designed to reduce the US’s reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities.According to the regulator, applicants who conduct any required bioequivalence testing in the US, and whose products are made there using exclusively domestic sources for active pharmaceutical […]
